I hear you loud and clear, and carry the same concerns. I was hopeful that as shareholders took advantage of the share conversion option, RSHN's PPS would finally recover.
One benefit to this change in plans however is that confusion has been delimited. Plain and simple, we have RSHN shares and they are worth what they are worth. Another potential benefit is that with all of the value under one entity (RSHN), that entity should receive a higher valuation after the acquisitions and thus increase eligibility for leaving the OTC land. It is what it is, I guess. I still believe in the company and where it is going, and have faith in the CEO's expressed desire to choose the route that best benefits the shareholders.
Still, as yourself, I am disappointed and can't help but to feel at least a little duped by this sudden change in plans.